Annual FCF
-$56.88 M
+$55.65 M+49.46%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual free cash flow is -$56.88 million, with the most recent change of +$55.65 million (+49.46%) on December 31, 2023.
- During the last 3 years, CTMX annual FCF has fallen by -$59.83 million (-2027.97%).
- CTMX annual FCF is now -133.69% below its all-time high of $168.81 million, reached on December 31, 2017.
Performance
CTMX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$20.75 M
-$1.10 M-5.61%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly free cash flow is -$20.75 million, with the most recent change of -$1.10 million (-5.61%) on September 30, 2024.
- Over the past year, CTMX quarterly FCF has dropped by -$2.50 million (-13.68%).
- CTMX quarterly FCF is now -112.00% below its all-time high of $172.87 million, reached on June 30, 2017.
Performance
CTMX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$88.78 M
-$2.50 M-2.89%
September 30, 2024
Summary
- As of February 7, 2025, CTMX TTM free cash flow is -$88.78 million, with the most recent change of -$2.50 million (-2.89%) on September 30, 2024.
- Over the past year, CTMX TTM FCF has dropped by -$52.56 million (-145.11%).
- CTMX TTM FCF is now -151.18% below its all-time high of $173.48 million, reached on March 31, 2018.
Performance
CTMX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CTMX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.5% | -13.7% | -145.1% |
| 3 y3 years | -2028.0% | -13.7% | -145.1% |
| 5 y5 years | +28.3% | -13.7% | -145.1% |
CTMX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.9% | -323.1% | +50.7% | -145.1% | +37.6% |
| 5 y | 5-year | -2028.0% | +60.5% | -121.4% | +59.1% | -489.2% | +42.3% |
| alltime | all time | -133.7% | +60.5% | -112.0% | +59.1% | -151.2% | +42.3% |
CytomX Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.75 M(+5.6%) | -$88.78 M(+2.9%) |
| Jun 2024 | - | -$19.64 M(-24.9%) | -$86.29 M(-6.6%) |
| Mar 2024 | - | -$26.16 M(+17.7%) | -$92.34 M(+62.3%) |
| Dec 2023 | -$56.88 M(-49.5%) | -$22.23 M(+21.8%) | -$56.88 M(+57.0%) |
| Sep 2023 | - | -$18.25 M(-29.0%) | -$36.22 M(-30.6%) |
| Jun 2023 | - | -$25.70 M(-376.3%) | -$52.22 M(-14.6%) |
| Mar 2023 | - | $9.30 M(-690.5%) | -$61.18 M(-45.6%) |
| Dec 2022 | -$112.53 M(-6.7%) | -$1.57 M(-95.4%) | -$112.53 M(-21.0%) |
| Sep 2022 | - | -$34.26 M(-1.1%) | -$142.39 M(+3.1%) |
| Jun 2022 | - | -$34.65 M(-17.6%) | -$138.10 M(+4.8%) |
| Mar 2022 | - | -$42.05 M(+33.8%) | -$131.77 M(+9.2%) |
| Dec 2021 | -$120.64 M(-4189.5%) | -$31.44 M(+4.9%) | -$120.64 M(+12.7%) |
| Sep 2021 | - | -$29.97 M(+5.8%) | -$107.08 M(+4.4%) |
| Jun 2021 | - | -$28.31 M(-8.4%) | -$102.56 M(-549.6%) |
| Mar 2021 | - | -$30.92 M(+73.0%) | $22.81 M(+673.4%) |
| Dec 2020 | $2.95 M(-102.0%) | -$17.87 M(-29.8%) | $2.95 M(-131.5%) |
| Sep 2020 | - | -$25.46 M(-126.2%) | -$9.36 M(+19.2%) |
| Jun 2020 | - | $97.06 M(-291.1%) | -$7.85 M(-94.9%) |
| Mar 2020 | - | -$50.79 M(+68.3%) | -$153.90 M(+6.9%) |
| Dec 2019 | -$143.98 M | -$30.18 M(+26.0%) | -$143.98 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$23.95 M(-51.1%) | -$143.66 M(+13.7%) |
| Jun 2019 | - | -$48.98 M(+19.9%) | -$126.31 M(+20.5%) |
| Mar 2019 | - | -$40.86 M(+36.8%) | -$104.81 M(+32.2%) |
| Dec 2018 | -$79.31 M(-147.0%) | -$29.86 M(+352.4%) | -$79.31 M(+186.5%) |
| Sep 2018 | - | -$6.60 M(-76.0%) | -$27.68 M(+3.0%) |
| Jun 2018 | - | -$27.48 M(+78.9%) | -$26.87 M(-115.5%) |
| Mar 2018 | - | -$15.36 M(-170.6%) | $173.48 M(+2.8%) |
| Dec 2017 | $168.81 M(-4111.7%) | $21.77 M(-475.6%) | $168.81 M(+13.8%) |
| Sep 2017 | - | -$5.79 M(-103.4%) | $148.38 M(+6.6%) |
| Jun 2017 | - | $172.87 M(-963.1%) | $139.13 M(-857.3%) |
| Mar 2017 | - | -$20.03 M(-1601.5%) | -$18.37 M(+336.6%) |
| Dec 2016 | -$4.21 M(-85.5%) | $1.33 M(-108.9%) | -$4.21 M(-69.7%) |
| Sep 2016 | - | -$15.04 M(-197.9%) | -$13.89 M(+99.1%) |
| Jun 2016 | - | $15.37 M(-362.0%) | -$6.98 M(-76.1%) |
| Mar 2016 | - | -$5.87 M(-29.7%) | -$29.25 M(+0.8%) |
| Dec 2015 | -$29.01 M(-196.3%) | -$8.35 M(+2.7%) | -$29.01 M(+40.4%) |
| Sep 2015 | - | -$8.13 M(+17.7%) | -$20.66 M(+64.9%) |
| Jun 2015 | - | -$6.91 M(+22.8%) | -$12.53 M(+122.8%) |
| Mar 2015 | - | -$5.62 M | -$5.62 M |
| Dec 2014 | $30.14 M(-444.8%) | - | - |
| Dec 2013 | -$8.74 M | - | - |
FAQ
- What is CytomX Therapeutics annual free cash flow?
- What is the all time high annual FCF for CytomX Therapeutics?
- What is CytomX Therapeutics annual FCF year-on-year change?
- What is CytomX Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly FCF year-on-year change?
- What is CytomX Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for CytomX Therapeutics?
- What is CytomX Therapeutics TTM FCF year-on-year change?
What is CytomX Therapeutics annual free cash flow?
The current annual FCF of CTMX is -$56.88 M
What is the all time high annual FCF for CytomX Therapeutics?
CytomX Therapeutics all-time high annual free cash flow is $168.81 M
What is CytomX Therapeutics annual FCF year-on-year change?
Over the past year, CTMX annual free cash flow has changed by +$55.65 M (+49.46%)
What is CytomX Therapeutics quarterly free cash flow?
The current quarterly FCF of CTMX is -$20.75 M
What is the all time high quarterly FCF for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly free cash flow is $172.87 M
What is CytomX Therapeutics quarterly FCF year-on-year change?
Over the past year, CTMX quarterly free cash flow has changed by -$2.50 M (-13.68%)
What is CytomX Therapeutics TTM free cash flow?
The current TTM FCF of CTMX is -$88.78 M
What is the all time high TTM FCF for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM free cash flow is $173.48 M
What is CytomX Therapeutics TTM FCF year-on-year change?
Over the past year, CTMX TTM free cash flow has changed by -$52.56 M (-145.11%)